Duration between aneurysm rupture and treatment and its association with outcome in aneurysmal subarachnoid haemorrhage
Standard
Duration between aneurysm rupture and treatment and its association with outcome in aneurysmal subarachnoid haemorrhage. / Hostettler, Isabel C; Lange, Nicole; Schwendinger, Nina; Frangoulis, Samira; Hirle, Theresa; Trost, Dominik; Gempt, Jens; Kreiser, Kornelia; Wostrack, Maria; Meyer, Bernhard.
in: SCI REP-UK, Jahrgang 13, Nr. 1, 27.01.2023, S. 1527.Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - Duration between aneurysm rupture and treatment and its association with outcome in aneurysmal subarachnoid haemorrhage
AU - Hostettler, Isabel C
AU - Lange, Nicole
AU - Schwendinger, Nina
AU - Frangoulis, Samira
AU - Hirle, Theresa
AU - Trost, Dominik
AU - Gempt, Jens
AU - Kreiser, Kornelia
AU - Wostrack, Maria
AU - Meyer, Bernhard
N1 - © 2023. The Author(s).
PY - 2023/1/27
Y1 - 2023/1/27
N2 - Timely treatment of aneurysmal subarachnoid haemorrhage (aSAH) is key to prevent further rupture and poor outcome. We evaluated complications and outcome adjusting for time from haemorrhage to treatment. Retrospective analysis of aSAH patients admitted between 2006 and 2020. Data was collected using standardized case report forms. We compared risk factors using multivariable logistic regression. We included 853 patients, 698 (81.8%) were treated within 24 h. Patients with higher Hunt and Hess grades were admitted and treated significantly faster than those with lower grades (overall p-value < 0.001). Fifteen patients (1.8%) rebled before intervention. In the multivariable logistic analysis adjusting for timing, Barrow Neurological Institute score and intracerebral haemorrhage were significantly associated with rebleeding (overall p-value 0.006; OR 3.12, 95%CI 1.09-8.92, p = 0.03, respectively) but timing was not. Treatment > 24 h was associated with higher mortality and cerebral infarction in only the subgroup of lower grades aSAH (OR 3.13, 1.02-9.58 95%CI, p-value = 0.05; OR 7.69, 2.44-25.00, p-value < 0.001, respectively). Therefore treatment > 24 h after rupture is associated with higher mortality and cerebral infarction rates in lower grades aSAH. Delay in treatment primarily affects lower grade aSAH patients. Patients with lower grade aSAH ought to be treated with the same urgency as higher-grade aSAH.
AB - Timely treatment of aneurysmal subarachnoid haemorrhage (aSAH) is key to prevent further rupture and poor outcome. We evaluated complications and outcome adjusting for time from haemorrhage to treatment. Retrospective analysis of aSAH patients admitted between 2006 and 2020. Data was collected using standardized case report forms. We compared risk factors using multivariable logistic regression. We included 853 patients, 698 (81.8%) were treated within 24 h. Patients with higher Hunt and Hess grades were admitted and treated significantly faster than those with lower grades (overall p-value < 0.001). Fifteen patients (1.8%) rebled before intervention. In the multivariable logistic analysis adjusting for timing, Barrow Neurological Institute score and intracerebral haemorrhage were significantly associated with rebleeding (overall p-value 0.006; OR 3.12, 95%CI 1.09-8.92, p = 0.03, respectively) but timing was not. Treatment > 24 h was associated with higher mortality and cerebral infarction in only the subgroup of lower grades aSAH (OR 3.13, 1.02-9.58 95%CI, p-value = 0.05; OR 7.69, 2.44-25.00, p-value < 0.001, respectively). Therefore treatment > 24 h after rupture is associated with higher mortality and cerebral infarction rates in lower grades aSAH. Delay in treatment primarily affects lower grade aSAH patients. Patients with lower grade aSAH ought to be treated with the same urgency as higher-grade aSAH.
KW - Humans
KW - Subarachnoid Hemorrhage/therapy
KW - Retrospective Studies
KW - Risk Factors
KW - Cerebral Infarction/complications
KW - Aneurysm, Ruptured/therapy
KW - Treatment Outcome
KW - Intracranial Aneurysm/complications
U2 - 10.1038/s41598-022-27177-9
DO - 10.1038/s41598-022-27177-9
M3 - SCORING: Journal article
C2 - 36707604
VL - 13
SP - 1527
JO - SCI REP-UK
JF - SCI REP-UK
SN - 2045-2322
IS - 1
ER -